PROF
Profound Medical Corp.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Positions exited
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Millennium Management 3× in & out | Q1 2026 | Q2 2026 | → $6.97 | +4% |
| Citadel Advisors | Q4 2024 | Q1 2026 | → $6.68 | -17% |
| Renaissance Technologies | Q4 2024 | Q2 2025 | → $4.04 | -51% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Profound Medical Corp.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 20, 2025 — the most recent Form 4 on file — not from today.
Fundamentals
XBRL · Profound Medical Corp.Annual figures sourced directly from Profound Medical Corp.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Profound Medical Corp. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KMay 15, 2026
- 8-KFORM 8-KMay 14, 2026
- S-3FORM S-3May 12, 2026
- 10-QQuarterly reportMay 7, 2026
- 8-KFORM 8-KMay 7, 2026
- 8-KFORM 8-KApr 16, 2026
- 8-KFORM 8-KApr 14, 2026
- 8-KFORM 8-KApr 1, 2026
- 8-KFORM 8-KMar 27, 2026
- 8-KFORM 8-KMar 13, 2026
- 8-KFORM 8-KMar 10, 2026
- 8-KFORM 8-KMar 9, 2026
- 10-KAnnual reportMar 5, 2026
- 8-KFORM 8-KMar 5, 2026
- 8-KFORM 8-KFeb 12, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q1 2026 | Q2 2026 | $6.68 | $6.97 | +4% |
| Millennium Management | Q2 2025 | Q3 2025 | $4.53 | $5.54 | +22% |
| Citadel Advisors | Q4 2024 | Q1 2026 | $8.01 | $6.68 | -17% |
| Millennium Management | Q4 2024 | Q1 2025 | $8.01 | $6.70 | -16% |
| Renaissance Technologies | Q4 2024 | Q2 2025 | $8.17 | $4.04 | -51% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.